These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23567302)

  • 1. [Quality of life and iron metabolism in patients with anemic syndrome developed on the background of chronic heart failure].
    Ryndina N; Kravchun P; Tytova G
    Georgian Med News; 2013 Mar; (216):16-9. PubMed ID: 23567302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disordered iron homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise capacity, and survival.
    Okonko DO; Mandal AK; Missouris CG; Poole-Wilson PA
    J Am Coll Cardiol; 2011 Sep; 58(12):1241-51. PubMed ID: 21903058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE; Lombraña A; Duarte P; Di Gennaro F
    J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ferric carboxymaltose in patients with heart failure and iron deficiency.
    Anker SD; Comin Colet J; Filippatos G; Willenheimer R; Dickstein K; Drexler H; Lüscher TF; Bart B; Banasiak W; Niegowska J; Kirwan BA; Mori C; von Eisenhart Rothe B; Pocock SJ; Poole-Wilson PA; Ponikowski P;
    N Engl J Med; 2009 Dec; 361(25):2436-48. PubMed ID: 19920054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment with iron of patients with heart failure with and without anemia.
    Jelani QU; Attanasio P; Katz SD; Anker SD
    Heart Fail Clin; 2010 Jul; 6(3):305-12. PubMed ID: 20630405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial.
    Okonko DO; Grzeslo A; Witkowski T; Mandal AK; Slater RM; Roughton M; Foldes G; Thum T; Majda J; Banasiak W; Missouris CG; Poole-Wilson PA; Anker SD; Ponikowski P
    J Am Coll Cardiol; 2008 Jan; 51(2):103-12. PubMed ID: 18191732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anemia and iron metabolism in patients with type-2 diabetes mellitus].
    Kovács F; Szakál I; Révész K; Lévai A; Dobos A
    Orv Hetil; 2006 Feb; 147(8):345-9. PubMed ID: 16579333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iron Status in Chronic Heart Failure: Impact on Symptoms, Functional Class and Submaximal Exercise Capacity.
    Enjuanes C; Bruguera J; Grau M; Cladellas M; Gonzalez G; Meroño O; Moliner-Borja P; Verdú JM; Farré N; Comín-Colet J
    Rev Esp Cardiol (Engl Ed); 2016 Mar; 69(3):247-55. PubMed ID: 26684058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between iron deficiency anemia and lipid metabolism in premenopausal women.
    Ozdemir A; Sevinç C; Selamet U; Türkmen F
    Am J Med Sci; 2007 Nov; 334(5):331-3. PubMed ID: 18004086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anemia in heart failure: association of hepcidin levels to iron deficiency in stable outpatients.
    Weber CS; Beck-da-Silva L; Goldraich LA; Biolo A; Clausell N
    Acta Haematol; 2013; 129(1):55-61. PubMed ID: 23147477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron deficiency is a key determinant of health-related quality of life in patients with chronic heart failure regardless of anaemia status.
    Comín-Colet J; Enjuanes C; González G; Torrens A; Cladellas M; Meroño O; Ribas N; Ruiz S; Gómez M; Verdú JM; Bruguera J
    Eur J Heart Fail; 2013 Oct; 15(10):1164-72. PubMed ID: 23703106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the IRON-HF study: a randomized trial to assess the effects of iron supplementation in heart failure patients with anemia.
    Beck-da-Silva L; Rohde LE; Pereira-Barretto AC; de Albuquerque D; Bocchi E; Vilas-Boas F; Moura LZ; Montera MW; Rassi S; Clausell N
    J Card Fail; 2007 Feb; 13(1):14-7. PubMed ID: 17338998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron deficiency and anaemia in heart failure: understanding the FAIR-HF trial.
    González-Costello J; Comín-Colet J
    Eur J Heart Fail; 2010 Nov; 12(11):1159-62. PubMed ID: 20855375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigation of iron deficiency in patients with congestive heart failure: A medical practice that requires greater attention.
    Belmar Vega L; de Francisco A; Albines Fiestas Z; Serrano Soto M; Kislikova M; Seras Mozas M; Unzueta MG; Arias Rodríguez M
    Nefrologia; 2016; 36(3):249-54. PubMed ID: 27056405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing iron status: beyond serum ferritin and transferrin saturation.
    Wish JB
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S4-8. PubMed ID: 17699374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor deficiency in the anemia of renal transplant patients with grade III-IV chronic kidney disease: baseline results of the ARES Study.
    Gentil MA; Pérez-Valdivia MA; López-Mendoza M; Ortega F; Arias M; Gómez-Alamillo C; Campistol JM;
    Transplant Proc; 2008 Nov; 40(9):2922-4. PubMed ID: 19010148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ferric carboxymaltose in correcting iron-deficiency anemia: a review of randomized controlled trials across different indications.
    Bailie GR
    Arzneimittelforschung; 2010; 60(6a):386-98. PubMed ID: 20648930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome.
    Besarab A; Hörl WH; Silverberg D
    Oncologist; 2009; 14 Suppl 1():22-33. PubMed ID: 19762514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron deficiency and health-related quality of life in chronic heart failure: results from a multicenter European study.
    Enjuanes C; Klip IT; Bruguera J; Cladellas M; Ponikowski P; Banasiak W; van Veldhuisen DJ; van der Meer P; Jankowska EA; Comín-Colet J
    Int J Cardiol; 2014 Jun; 174(2):268-75. PubMed ID: 24768464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintaining higher TSATs and other iron indices is beneficial in management of anemic hemodialysis patients.
    Besarab A; Dalton CL
    Nephrol Nurs J; 2001 Aug; 28(4):429-34. PubMed ID: 12143465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.